市場調査レポート

商品コード

1722418

手術部位感染対策市場レポート：製品タイプ、感染タイプ、手術タイプ、エンドユーザー、地域別、2025年～2033年

Surgical Site Infection Control Market Report by Product, Infection Type, Surgery Type, End User, and Region 2025-2033

出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 2,999 438,093円

レポートPDFおよびExcelを1名のみがご利用頂けるライセンスです。PDFおよびExcelの印刷は一度のみ可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (5 User License)

USD 3,999 584,173円

レポートPDFおよびExcelを同一企業内の5名様までがご利用頂けるライセンスです。PDFおよびExcelの印刷は可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Corporate License)

USD 4,999 730,253円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等の編集は可能ですが、事前にIMARC Services Private Limited社の許可が必要です。PDFおよびExcelの印刷回数に制限はありません。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.08円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の手術部位感染対策市場規模は2024年に48億米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに67億米ドルに達し、2025年から2033年にかけて3.59%の成長率（CAGR）を示すと予測しています。外科手術の増加、ヘルスケア関連感染に対する意識の高まり、患者の安全性への関心の高まり、医療費の急増などが、市場成長を後押しする主な要因となっています。

手術部位感染対策市場分析：

主な市場促進要因：高齢化、座りがちなライフスタイル、不健康な食習慣などにより、院内感染の増加や、がん、消化器疾患、心血管疾患（CVDs）などの慢性疾患の有病率の増加が、手術部位感染対策の採用を促進しています。さらに、各国の政府機関や非政府機関により、厳格なガイドラインの導入や感染制御の実践に焦点を当てたトレーニングプログラムなど、有利なイニシアチブがいくつか実施されていることも、手術部位感染対策市場を促進しています。

主な市場動向：手術部位感染のイントロダクションの増加、感染制御製品の技術的進歩の継続、低侵襲手術の採用の増加、厳格な規制基準の導入などが、手術部位感染対策市場の需要を促進すると予測されています。さらに、世界のヘルスケア支出の増加に伴い、患者の転帰を改善し、SSIを含む医療関連感染を減らすことに注目が集まっています。この動向は、手術環境における高度な感染制御ソリューションの需要を促進すると予想されます。

競合情勢：手術部位感染対策市場の主要企業としては、3M Company、Ansell Limited、Becton Dickinson and Company、bioMerieux SA.（Institut Merieux）、Covalon Technologies Ltd.、GAMA Healthcare Ltd.、Getinge AB（Carl Bennet AB）、Johnson &Johnson、Kimberly-Clark Corporation、Molnlycke Health Care AB、Prescient Surgical、Steris Corporationなどです。

地理的動向：報告書によると、北米は現在市場全体を支配しています。同地域は、手術部位感染対策製品およびサービスの世界最大級の市場です。市場規模は、手術件数の増加、高度なヘルスケアインフラ、幅広い規制状況、進行中の技術革新などの要因に影響されています。ヘルスケア関連感染に対する意識の高まりと感染予防対策の重要性により、市場は着実な成長を遂げています。

課題と機会：抗生物質耐性、コンプライアンス上の問題、コストへの配慮、医療施設による手術方法やプロトコルの違いなどは、市場が直面している課題の一部です。しかし、抗菌性コーティング、新規手術材料、ロボット支援手術の開発などの医療技術の動向は、手術部位感染対策市場に手術環境における感染管理を強化する最近の機会を提供しています。

手術部位感染対策市場の動向：

老年人口の増加

世界の多くの地域で、65歳以上の高齢者の割合の増加を特徴とする人口動態の変化が起きています。例えば、世界保健機関（WHO）によると、2030年までに世界の6人に1人が60歳以上となります。この時、60歳以上の人口比率は2020年の10億人から14億人に増加します。2050年には、世界の60歳以上の人口は2倍（21億人）になります。80歳以上の人口は2020年から2050年の間に3倍になり、4億2,600万人に達すると予想されています。高齢者は、加齢に伴う免疫系の変化、組織治癒能力の低下、糖尿病、高血圧、心血管疾患などの併存疾患の存在により、SSIに対してより脆弱です。老年人口の増加に伴い、高齢者に行われる外科手術の数も増加し、SSIのリスクを軽減するための感染管理対策への需要が高まっています。例えば、国立医学図書館が2021年3月に発表した論文によると、65歳以上の高齢者に対して毎年400万件近くの外科手術が行われています。これと同様に、2023年3月に国立医学図書館が発表した別の論文によると、人工膝関節全置換術では、61～65歳の年齢層と比較して、76～80歳の高齢者ではSSI発生率が高かったです。これらの要因は、手術部位感染市場の収益をさらに押し上げています。

手術手技の増加とヘルスケアインフラ開発

世界中で外科手術が大幅に増加しています。例えば、国立医学図書館が発表した論文によると、2020年9月には、世界の疾病負担の11％が外科的介入、麻酔管理、またはその両方を必要としています。最も多い手術は、白内障（22.8％）、帝王切開（3.8％）、骨折手術（3.27％）、ヘルニア（2.86％）です。必要な手術は全手術の44.2％を占めました。さらに、特に新興国市場におけるヘルスケアインフラ開拓の取り組みが、手術部位感染対策市場の成長に寄与しています。India Investment Gridが発表した記事によると、公的医療支出は2025年までにGDPの2.5%に上昇すると予想されています。これとは別に、ヘルスケア施設やプロバイダーは、SSIの発生を最小限に抑えるための予防戦略や技術への投資を増やしています。これには、厳格なプロトコルの採用、高度な滅菌技術、手術器具の抗菌コーティング、創傷被覆材や縫合糸におけるハイテク素材の利用などが含まれます。例えば、2023年12月、フリンダース大学と中国の研究者が共同で、感染に強い新しいAg-Ga整形外科用インプラントの被覆材を開発しました。この新素材は、多数の医療器具にスプレーキャストすることで、感染から保護すると同時に、抗炎症作用も発揮するため、容易かつ制御可能です。さらに、2023年10月、Sylke Inc.は、純粋な低アレルギー性絹フィブロインから製造されたドレッシング材SYLKEを発表しました。SYLKEは手術創の治癒を促進し、瘢痕形成不全の原因となる合併症や感染症を軽減します。SYLKEは、感染症や劣悪な瘢痕形成の原因となる医療用接着剤に関連した皮膚損傷を取り除くことで、手術創ケアの変革を目指します。

調査研究と臨床試験の進歩

研究開発と臨床試験の進展は、革新的な製品の開発を促進し、治療戦略を強化し、患者の転帰を改善することで、手術部位感染対策市場の成長を促進する重要な役割を果たしています。例えば、2024年2月、外科手術の予後を改善するバイオ医薬品企業であるポリピッド社は、100人目の患者を登録した後、SHIELD II第3相臨床試験で大きな進展があったことを発表しました。この調査は、腹部大腸手術における手術部位感染（SSI）予防を目的とした製品候補であるD-PLEX100の有効性を調べたものです。SHIELD II試験のトップライン結果は2024年後半に期待され、約40ヵ所がこの試験に積極的に参加しています。さらに、調査研究および臨床試験は、手術環境における感染予防および制御のためのベストプラクティスおよびガイドラインの特定に貢献しています。術前準備、手術手技、抗菌薬予防、術後ケアに関するエビデンスに基づく推奨は、プロトコルの標準化と感染対策の遵守向上に役立ち、最終的にSSIの発生率を低下させ、患者の転帰を改善します。例えば、2023年8月にエモリー大学が実施した調査では、2万人以上の患者を対象に、自動化された方法でフィードバックを行い、パフォーマンスを評価したところ、抗生物質予防投与の遵守率が12％増加し、SSI全体が33％減少しました。Surgical Infection Society（外科感染学会）の2023年年次総会で発表されたデータでは、独自の自動化された抗生物質予防投与アプローチが手術部位感染を大幅に減少させることが示されました。これらの要因は、手術部位感染対策市場予測にさらにプラスの影響を与えています。

北米
- 米国
- カナダ
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
ラテンアメリカ
- ブラジル
- メキシコ
- その他
中東・アフリカ
- 市場内訳：国別

第11章 SWOT分析

概要
強み
弱み
機会
脅威

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

概要
買い手の交渉力
供給企業の交渉力
競合の程度
新規参入業者の脅威
代替品の脅威

第14章価格分析

第15章競合情勢

市場構造
主要企業
主要企業のプロファイル
- 3M Company
- Ansell Limited
- Becton Dickinson and Company
- bioMerieux SA.（Institut Merieux）
- Covalon Technologies Ltd.
- GAMA Healthcare Ltd.
- Getinge AB（Carl Bennet AB）
- Johnson & Johnson
- Kimberly-Clark Corporation
- Molnlycke Health Care AB
- Prescient Surgical
- Steris Corporation

図表

List of Figures

Figure 1: Global: Surgical Site Infection Control Market: Major Drivers and Challenges
Figure 2: Global: Surgical Site Infection Control Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Surgical Site Infection Control Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Surgical Site Infection Control Market: Breakup by Product (in %), 2024
Figure 5: Global: Surgical Site Infection Control Market: Breakup by Infection Type (in %), 2024
Figure 6: Global: Surgical Site Infection Control Market: Breakup by Surgery Type (in %), 2024
Figure 7: Global: Surgical Site Infection Control Market: Breakup by End User (in %), 2024
Figure 8: Global: Surgical Site Infection Control Market: Breakup by Region (in %), 2024
Figure 9: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Surgical Site Infection Control (Antibiotic Prophylaxis Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Surgical Site Infection Control (Wound Care Dressings) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Surgical Site Infection Control (Wound Care Dressings) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Surgical Site Infection Control (Surgical Drapes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Surgical Site Infection Control (Surgical Drapes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Surgical Site Infection Control (Surgical Clippers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Surgical Site Infection Control (Surgical Clippers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Surgical Site Infection Control (Antiseptics and Disinfectants) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Surgical Site Infection Control (Wound Irrigation Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Surgical Site Infection Control (Wound Irrigation Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Surgical Site Infection Control (Other Products) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Surgical Site Infection Control (Other Products) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Surgical Site Infection Control (Superficial Incisional SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Surgical Site Infection Control (Deep Incisional SSI) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Surgical Site Infection Control (Deep Incisional SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Surgical Site Infection Control (Organ or Space SSI) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Surgical Site Infection Control (Organ or Space SSI) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Surgical Site Infection Control (Cesarean Section) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Surgical Site Infection Control (Cesarean Section) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Surgical Site Infection Control (Gastric Bypass) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Surgical Site Infection Control (Gastric Bypass) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Surgical Site Infection Control (Cataract Surgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Surgical Site Infection Control (Cataract Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Surgical Site Infection Control (Dental Restoration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Surgical Site Infection Control (Dental Restoration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Surgical Site Infection Control (Other Surgery Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Surgical Site Infection Control (Other Surgery Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Surgical Site Infection Control (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Surgical Site Infection Control (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Global: Surgical Site Infection Control (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Global: Surgical Site Infection Control (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Global: Surgical Site Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: North America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: North America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: United States: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: United States: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Canada: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Canada: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Asia-Pacific: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Asia-Pacific: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: China: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: China: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Japan: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Japan: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: India: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: India: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: South Korea: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: South Korea: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Australia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Australia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Indonesia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Indonesia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Europe: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Europe: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Germany: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Germany: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: France: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: France: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: United Kingdom: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: United Kingdom: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Italy: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Italy: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Spain: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Spain: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Russia: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Russia: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Latin America: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Latin America: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Brazil: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Brazil: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Mexico: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Mexico: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Others: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 90: Others: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 91: Middle East and Africa: Surgical Site Infection Control Market: Sales Value (in Million USD), 2019 & 2024
Figure 92: Middle East and Africa: Surgical Site Infection Control Market: Breakup by Country (in %), 2024
Figure 93: Middle East and Africa: Surgical Site Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 94: Global: Surgical Site Infection Control Industry: SWOT Analysis
Figure 95: Global: Surgical Site Infection Control Industry: Value Chain Analysis
Figure 96: Global: Surgical Site Infection Control Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Surgical Site Infection Control Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Surgical Site Infection Control Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Surgical Site Infection Control Market Forecast: Breakup by Infection Type (in Million USD), 2025-2033
Table 4: Global: Surgical Site Infection Control Market Forecast: Breakup by Surgery Type (in Million USD), 2025-2033
Table 5: Global: Surgical Site Infection Control Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Surgical Site Infection Control Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Surgical Site Infection Control Market: Competitive Structure
Table 8: Global: Surgical Site Infection Control Market: Key Players

Product Code: SR112025A5669

The global surgical site infection control market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.59% during 2025-2033. The increasing surgical procedures, growing awareness about healthcare-associated infections, enhanced focus on patient safety, and surging healthcare expenditure are some of the major factors propelling the market growth.

Surgical Site Infection Control Market Analysis:

Major Market Drivers: The rising cases of hospital-acquired infections and the increasing prevalence of chronic conditions, such as cancer, gastrointestinal disorders, cardiovascular diseases (CVDs), etc., due to the aging population, sedentary lifestyles, and unhealthy eating habits are propelling the adoption of surgical site infection control. Moreover, several favorable initiatives undertaken by the governing and non-governing agencies of various countries, such as the introduction of stringent guidelines and training programs focused on infection control practices, are propelling the surgical site infection control market.

Key Market Trends: The increasing prevalence of surgical site infections, ongoing technological advancements in infection control products, rising adoption of minimally invasive surgeries, and introduction of stringent regulatory standards are expected to propel the surgical site infection control market demand. Moreover, with the rise in healthcare expenditure globally, there is a growing focus on improving patient outcomes and reducing healthcare-associated infections, including SSIs. This trend is expected to drive the demand for advanced infection control solutions in surgical settings.

Competitive Landscape: Some of the leading surgical site infection control market companies are 3M Company, Ansell Limited, Becton Dickinson and Company, bioMerieux SA. (Institut Merieux), Covalon Technologies Ltd., GAMA Healthcare Ltd., Getinge AB (Carl Bennet AB), Johnson & Johnson, Kimberly-Clark Corporation, Molnlycke Health Care AB, Prescient Surgical, and Steris Corporation, among many others.

Geographical Trends: According to the report, North America currently dominates the overall market. The region represents one of the largest markets for surgical site infection control products and services globally. The market size is influenced by factors such as the increase in the number of surgical procedures, advanced healthcare infrastructures, wide presence of regulatory landscape, ongoing technological innovations, etc. The market has been experiencing steady growth due to the increasing awareness about healthcare-associated infections and the importance of infection prevention measures.

Challenges and Opportunities: Antibiotic resistance, compliance issues, cost consideration, and variations in surgical practices and protocols across different healthcare facilities are some of the challenges that the market is facing. However, advances in medical technology, such as the development of antimicrobial coatings, novel surgical materials, and robotic-assisted surgery, offer the surgical site infection control market recent opportunities to enhance infection control in surgical settings.

Surgical Site Infection Control Market Trends:

Rising Geriatric Population

Many regions worldwide are experiencing a demographic shift characterized by a growing proportion of older adults aged 65 and above. For instance, according to the World Health Organization, by 2030, one in every six persons in the world will be 60 or older. At this time, the proportion of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By 2050, the global population of persons aged 60 and up will double (2.1 billion). The number of people aged 80 and older is anticipated to treble between 2020 and 2050, reaching 426 million. Older adults are more vulnerable to SSIs due to age-related changes in the immune system, reduced tissue healing capacity, and the presence of comorbidities such as diabetes, hypertension, and cardiovascular disease. As the geriatric population grows, there is a corresponding increase in the number of surgical procedures performed on older adults, leading to a higher demand for infection control measures to mitigate the risk of SSIs. For instance, according to an article published by the National Library of Medicine in March 2021, nearly 4 million surgical procedures were performed each year in older adults aged 65 years and above. In line with this, according to another article published by the National Library of Medicine in March 2023, in total knee replacement surgery, the SSI rates were higher in older adults aged 76-80 years when compared with the age group of 61-65 years. These factors are further bolstering the surgical site infection market revenue.

Increasing Surgical Procedure and Healthcare Infrastructure Development

There has been a significant increase in surgical procedures across the world. For instance, according to an article published by the National Library of Medicine, in September 2020, 11% of the world's illness burden necessitates surgical intervention, anesthetic management, or both. The most common procedures were for cataracts (22.8%), Caesareans (3.8%), fracture surgeries (3.27%), and hernias (2.86%). The necessary operations made up 44.2% of all surgeries. Moreover, healthcare infrastructure development initiatives, particularly in emerging markets, contribute to the growth of the surgical site infection control market. According to an article published by the India Investment Grid, public health expenditure is expected to rise to 2.5% of GDP by 2025. Apart from this, healthcare facilities and providers are increasingly investing in preventive strategies and technologies to minimize the incidence of SSIs. This includes the adoption of stringent protocols, advanced sterilization techniques, antimicrobial coatings for surgical instruments, and the utilization of high-tech materials in wound dressings and sutures. For instance, in December 2023, Flinders University and Chinese researchers collaborated to develop a new Ag-Ga orthopedic implant covering that is highly resistant to infection. The novel material could be readily and controllably put by spray-casting on numerous medical devices to protect them from infection while simultaneously providing an anti-inflammatory impact. Moreover, in October 2023, Sylke Inc. introduced SYLKE, the dressing manufactured from pure hypoallergenic silk fibroin. SYLKE promotes healing in surgical wounds and reduces complications and infections that might cause poor scarring. SYLKE seeks to transform surgical wound care by removing medical adhesive-related skin damage that causes infections and poor scarring outcomes.

Advances in Research Studies and Clinical Trials

Advances in research studies and clinical trials play a crucial role in driving growth in the surgical site infection control market by facilitating the development of innovative products, enhancing treatment strategies, and improving patient outcomes. For instance, in February 2024, PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures. Top-line results from the SHIELD II trial were expected in the second half of 2024, with about 40 locations actively participating in the study. Moreover, research studies and clinical trials contribute to the identification of best practices and guidelines for infection prevention and control in surgical settings. Evidence-based recommendations regarding preoperative preparation, surgical techniques, antimicrobial prophylaxis, and postoperative care help standardize protocols and improve adherence to infection control measures, ultimately reducing the incidence of SSIs and improving patient outcomes. For instance, in August 2023, Emory University performed research which included over 20,000 patients and used automated methods to provide feedback and evaluate performance, found a 12% increase in antibiotic prophylactic compliance and a 33% decrease in overall SSIs. Data presented at the Surgical Infection Society's 2023 annual meeting showed that a unique automated antibiotic prophylaxis approach significantly reduces surgical site infections. These factors are further positively influencing the surgical site infection control market forecast.

Surgical Site Infection Control Key Market Segmentation:

Breakup by Product:

Antibiotic Prophylaxis Products
Wound Care Dressings
Surgical Drapes
Surgical Clippers
Antiseptics and Disinfectants
Wound Irrigation Products
Others

Antibiotic prophylaxis products currently exhibit a clear dominance in the market

According to the surgical site infection control market outlook, antibiotic prophylaxis plays a crucial role in preventing surgical site infections (SSIs), which are a significant concern in healthcare settings. Antibiotics are usually administered shortly before surgical incision to achieve adequate tissue concentrations at the time of potential bacterial contamination. The timing of administration is critical and should ideally occur within 60 minutes before the surgical incision, although exceptions may exist for certain antibiotics and procedures. Moreover, prophylactic antibiotic regimens are often tailored to the specific requirements of different surgical procedures. For example, orthopedic surgeries may require coverage against Staphylococcus aureus and streptococci, while colorectal surgeries may necessitate additional coverage against gram-negative and anaerobic bacteria. For instance, in January 2024, the American Association for the Surgery of Trauma (AAST), the World Surgical Infection Society Europe (SIS-E), the Global Alliance for Infection in Surgery (GAIS), and the World Society of Emergency Surgery (WSES) collaborated to develop important guidelines for antibiotic prophylaxis (AP) in cases of traumatic lesions involving the head, brain, torso, maxillofacial region, extremities, skin, and soft tissues.

Breakup by Infection Type:

Superficial Incisional SSI
Deep Incisional SSI
Organ or Space SSI

Currently, superficial incisional SSI accounts for the majority of the global market share

According to the surgical site infection market overview, superficial incisional surgical site infections (SSIs) represent a significant portion of all SSIs. These infections occur within 30 days after the operation and involve only the skin and subcutaneous tissue of the incision. They are often characterized by symptoms such as redness, warmth, swelling, and localized pain at the surgical site. They are among the most common types of SSIs encountered in surgical practice. Their relatively high incidence underscores their importance in infection control efforts. For instance, according to an article published by the National Library of Medicine in 2023, 59% of the total SSI patients had superficial SSI.

Breakup by Surgery Type:

Cesarean Section
Gastric Bypass
Cataract Surgery
Dental Restoration
Others

Cesarean section currently holds the largest market share

Cesarean sections are one of the most common surgical procedures globally. In many countries, the rates of C-section deliveries have been increasing steadily over the years. With such a high volume of procedures, the prevention of SSIs in C-sections becomes a significant focus of infection control efforts. Moreover, the surgical site in a Cesarean section is particularly vulnerable to infection due to its proximity to the genital and gastrointestinal tracts, which harbor numerous bacteria. Additionally, the procedure involves breaching the protective barriers of the skin and uterine wall, increasing the risk of contamination. Apart from this, SSIs following Cesarean sections can have serious consequences for both the mother and the newborn. In addition to causing discomfort and prolonging hospital stays for the mother, SSIs can lead to complications such as endometritis, wound dehiscence, sepsis, and increased healthcare costs. There's also a risk of vertical transmission of pathogens to the newborn, which can result in neonatal infections. For instance, according to World Health Organization (WHO) data, the use of cesarean sections is increasing, accounting for more than one in every five (21%) childbirths in 2021. This figure is expected to rise further over the next decade, with almost one-third (29%) of all births by cesarean section by 2030.

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Currently, hospitals exhibit a clear dominance in the market

The demand for surgical site infection (SSI) control in hospitals arises from various factors related to patient safety, healthcare quality, regulatory requirements, and financial considerations. Preventing SSIs is essential for ensuring patient safety and minimizing the risk of postoperative complications. SSIs can lead to significant morbidity, prolonged hospital stays, increased healthcare costs, and in severe cases, mortality. Hospitals have a moral and ethical obligation to provide safe and high-quality care to their patients, which includes implementing measures to control SSIs. Moreover, hospitals are increasingly focused on delivering high-quality care and maintaining a positive reputation within their communities. Preventing SSIs is a fundamental aspect of healthcare quality improvement efforts. Hospitals that effectively control SSIs are perceived as safer and more reliable by patients, healthcare professionals, insurers, and regulatory agencies.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America currently dominates the global market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America currently dominates the global market.

According to the surgical site infection control market statistics, North America represents one of the largest markets for healthcare products and services globally. Within this context, the SSI control market encompasses a wide range of products, including antimicrobial agents, surgical drapes, gloves, sterilization equipment, wound care products, and surveillance systems. Despite advances in surgical techniques and infection control practices, SSIs remain a significant concern in North American healthcare facilities. The prevalence of SSIs varies across different surgical specialties and settings but represents a substantial clinical and economic burden on healthcare systems. For instance, in February 2021, Penn Medicine opened its new Interventional Support Center (ISC), making it one of the most prominent instrument processing and surgical supply preparation facilities in Southwest Philadelphia, United States. The ISC is one of Pennsylvania's first facilities of its sort, with staff sterilizing and packaging thousands of instruments daily in preparation for surgeries and procedures, ranging from basic scissors and clamps to complex robotic instruments. For instance, according to an article published by the National Library of Medicine, in February 2024, surgical site infections accounted for approximately two million nosocomial infections in the U.S., which considerably raises postoperative morbidity and mortality rates. In line with this, according to the international trial co-led by McMaster University and the University of Maryland School of Medicine in February 2024, thousands of patients yearly undergoing surgery for a closed fracture may avoid surgical site infections by using iodine povacrylex in alcohol to disinfect their skin.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players that are mentioned below:

3M Company
Ansell Limited
Becton Dickinson and Company
bioMerieux SA. (Institut Merieux)
Covalon Technologies Ltd.
GAMA Healthcare Ltd.
Getinge AB (Carl Bennet AB)
Johnson & Johnson
Kimberly-Clark Corporation
Molnlycke Health Care AB
Prescient Surgical
Steris Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Surgical Site Infection Control Market Recent Developments:

May 2024: Nanordica Medical, an Estonian medical technology firm, received €1.75 million to enter the market with first-in-class wound care solutions that treat serious wounds.

April 2024: Vomaris launched PowerHeal, a bioelectric bandage approved by the FDA for over-the-counter (OTC) use in the management of wounds.

February 2024: PolyPid Ltd., a biopharmaceutical company dedicated to improving surgical outcomes, announced considerable progress in its SHIELD II Phase 3 clinical study, after enrolling its 100th patient. This research looked at the efficacy of D-PLEX100, a product candidate intended to prevent surgical site infections (SSIs) in abdominal colorectal procedures.

Key Questions Answered in This Report

1.How big is the surgical site infection control market?
2.What is the expected growth rate of the global surgical site infection control market during 2025-2033?
3.What are the key factors driving the global surgical site infection control market?
4.What has been the impact of COVID-19 on the global surgical site infection control market?
5.What is the breakup of the global surgical site infection control market based on the product?
6.What is the breakup of the global surgical site infection control market based on the infection type?
7.What is the breakup of the global surgical site infection control market based on the surgery type?
8.What is the breakup of the global surgical site infection control market based on the end user?
9.What are the key regions in the global surgical site infection control market?
10.Who are the key players/companies in the global surgical site infection control market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Surgical Site Infection Control Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Antibiotic Prophylaxis Products
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Wound Care Dressings
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Surgical Drapes
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Surgical Clippers
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Antiseptics and Disinfectants
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
6.6 Wound Irrigation Products
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
6.7 Others
- 6.7.1 Market Trends
- 6.7.2 Market Forecast

7 Market Breakup by Infection Type

7.1 Superficial Incisional SSI
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Deep Incisional SSI
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Organ or Space SSI
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Surgery Type

8.1 Cesarean Section
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Gastric Bypass
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Cataract Surgery
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Dental Restoration
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Ambulatory Surgical Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 3M Company
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Ansell Limited
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Becton Dickinson and Company
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 bioMerieux SA. (Institut Merieux)
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Covalon Technologies Ltd.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 GAMA Healthcare Ltd.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Getinge AB (Carl Bennet AB)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Johnson & Johnson
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Kimberly-Clark Corporation
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Molnlycke Health Care AB
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 SWOT Analysis
- 15.3.11 Prescient Surgical
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
- 15.3.12 Steris Corporation
  - 15.3.12.1 Company Overview
  - 15.3.12.2 Product Portfolio

手術部位感染対策市場レポート：製品タイプ、感染タイプ、手術タイプ、エンドユーザー、地域別、2025年～2033年

Surgical Site Infection Control Market Report by Product, Infection Type, Surgery Type, End User, and Region 2025-2033

手術部位感染対策市場分析：

手術部位感染対策市場の動向：

目次

第1章 序文

第2章 調査範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の手術部位感染対策市場

第6章 市場内訳：製品別

第7章 市場内訳：感染タイプ別

第8章 市場内訳：手術タイプ別

第9章 市場内訳：エンドユーザー別

第10章 市場内訳：地域別

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 価格分析

第15章 競合情勢